Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer

Tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR-TKIs) are standard treatments for advanced non-small-cell lung cancer (NSCLC) patients harboring activating epidermal growth factor receptor (EGFR) mutations. Nowadays, tumor tissues acquired by surgery or biopsy are the routine ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wei, Yuan, Xun, Tian, Yijun, Wu, Hua, Xu, Hanxiao, Hu, Guoqing, Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521383/
https://www.ncbi.nlm.nih.gov/pubmed/26227959
http://dx.doi.org/10.1186/s13045-015-0193-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521383/
https://www.ncbi.nlm.nih.gov/pubmed/26227959
http://dx.doi.org/10.1186/s13045-015-0193-6

Ejemplares similares